BACKGROUND: In conjunction with allergens, diesel exhaust particles act as an adjuvant to enhance IgE responses, inducing expression of cytokines/chemokines and adhesion molecules, and increasing airway hyper-responsiveness (AHR). As most studies were designed to expose animals to diesel exhaust throughout the periods of both sensitization and allergen challenge, it remains unclear whether diesel exhaust (DE) exposure exaggerates airway responses in asthmatic animals. OBJECTIVE: To study effects of exposure to low-dose DE on AHR and allergic airway inflammation in asthmatic mice. METHODS: BALB/c mice were sensitized by intraperitoneal injection of ovalbumin and challenged by intranasal administration with ovalbumin. They were exposed to low-dose DE for 7 h/day, 5 days/week, for up to 12 weeks. AHR to methacholine was evaluated by whole-body plethysmography as well as bronchoalveolar lavage cell analysis and cytokine gene expression in lungs. RESULTS: Repeated exposure of asthmatic mice to low-dose DE resulted in increased AHR and gene expression of several pro-asthmatic cytokines/chemokines, but these effects rapidly subsided with continued exposure to DE. CONCLUSION: Repeated exposure to low-dose DE after ovalbumin challenge exaggerates allergic responses in mice, but effects are not prolonged with continuous DE exposure.
BACKGROUND: In conjunction with allergens, diesel exhaust particles act as an adjuvant to enhance IgE responses, inducing expression of cytokines/chemokines and adhesion molecules, and increasing airway hyper-responsiveness (AHR). As most studies were designed to expose animals to diesel exhaust throughout the periods of both sensitization and allergen challenge, it remains unclear whether diesel exhaust (DE) exposure exaggerates airway responses in asthmatic animals. OBJECTIVE: To study effects of exposure to low-dose DE on AHR and allergic airway inflammation in asthmatic mice. METHODS: BALB/c mice were sensitized by intraperitoneal injection of ovalbumin and challenged by intranasal administration with ovalbumin. They were exposed to low-dose DE for 7 h/day, 5 days/week, for up to 12 weeks. AHR to methacholine was evaluated by whole-body plethysmography as well as bronchoalveolar lavage cell analysis and cytokine gene expression in lungs. RESULTS: Repeated exposure of asthmatic mice to low-dose DE resulted in increased AHR and gene expression of several pro-asthmatic cytokines/chemokines, but these effects rapidly subsided with continued exposure to DE. CONCLUSION: Repeated exposure to low-dose DE after ovalbumin challenge exaggerates allergic responses in mice, but effects are not prolonged with continuous DE exposure.
Authors: Terry L Noah; Haibo Zhou; Hongtao Zhang; Katie Horvath; Carole Robinette; Matthew Kesic; Megan Meyer; David Diaz-Sanchez; Ilona Jaspers Journal: Am J Respir Crit Care Med Date: 2011-10-27 Impact factor: 21.405
Authors: Xuedong Kang; Ning Li; Meiying Wang; Pinmanee Boontheung; Constantinos Sioutas; Jack R Harkema; Lori A Bramble; Andre E Nel; Joseph A Loo Journal: Proteomics Date: 2010-02 Impact factor: 3.984
Authors: Ning Li; Jack R Harkema; Ryan P Lewandowski; Meiying Wang; Lori A Bramble; Glenn R Gookin; Zhi Ning; Michael T Kleinman; Constantinos Sioutas; Andre E Nel Journal: Am J Physiol Lung Cell Mol Physiol Date: 2010-06-18 Impact factor: 5.464
Authors: Jessica P Ryman-Rasmussen; Earl W Tewksbury; Owen R Moss; Mark F Cesta; Brian A Wong; James C Bonner Journal: Am J Respir Cell Mol Biol Date: 2008-09-11 Impact factor: 6.914
Authors: Ning Li; Meiying Wang; Lori A Bramble; Debra A Schmitz; James J Schauer; Constantinos Sioutas; Jack R Harkema; Andre E Nel Journal: Environ Health Perspect Date: 2009-03-11 Impact factor: 9.031
Authors: Tania Maes; Sharen Provoost; Ellen A Lanckacker; Didier D Cataldo; Jeroen A J Vanoirbeek; Benoit Nemery; Kurt G Tournoy; Guy F Joos Journal: Respir Res Date: 2010-01-21